[ad_1] At the beginning of November, the Spanish capital and its region (6.5 million inhabitants) were identified as the European epicenter of the pandemic, with an incidence rate covering 800 cases per 100,000 inhabitants. There was panic on board, against the backdrop of a fierce political battle between regional authorities …
Read More »Promising SARS-CoV-2 N epitope for more accurate diagnostic and surveillance testing
[ad_1] The 2019 coronavirus disease (COVID-19) pandemic calls for better and faster tests to ensure more accurate diagnosis, monitoring and surveillance of the disease and its spread. Serological testing is used to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection after the acute phase. A new study published on …
Read More »Research shows a unique repertoire of T cell receptors in MIS-C patients
[ad_1] Children with coronavirus disease 2019 (COVID-19) sometimes develop multisystem inflammatory syndrome in children (MIS-C), which is associated with high morbidity. The underlying mechanism associated with T cells is described by the researchers in a new study published on the prepress server bioRxiv* in November 2020, in response to superantigen …
Read More »Results of the Phase 1 trial of the gorilla adenovirus vaccine for COVID-19
[ad_1] A recent study published on the prepress server bioRxiv* in October 2020 reports the development of a new vaccine based on a simian adenoviral vector obtained from a group C gorilla isolate called GRAd32. This could help accelerate vaccine development. Low seroprevalence for simian adenoviruses Monkey adenoviruses are isolated …
Read More »